Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I clinical trial to evaluate the safety and immunogenicity of the recombinant protein vaccine EP-1043 and the DNA vaccine EP HIV-1090 given alone and in combination to healthy, HIV-1-uninfected adult participants
Description
HVTN 064 is a Phase I clinical trial to evaluate the safety and immunogenicity of recombinant protein vaccine EP-1043 and the DNA vaccine EP HIV-1090.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.